Compounded semaglutide, for one, isnt user-intuitive, requiring patients to draw up doses in vials rather than use pre-filled pens
Gave me energy but no weight loss yetbut hopeful Still in the early stages my second order
Semaglutides multiple benefits can help lower blood sugar, reduce body weight, and lower the risk of cardiovascular eventslike heart attack, stroke, or heart diseasein millions of patients
Even in favorable head-to-head comparisons, oral GLP-1 therapies have demonstrated weight loss outcomes of approximately 1216%, while leading injectable therapies consistently deliver around 1722% or higher
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, producing more pronounced effects on appetite, insulin secretion, and energy expenditure than single or dual agonists
[PMID: 41467632] PubMed record related to this compound for laboratory literature review